可持续解决抗微生物耐药性的持续威胁的可持续解决方案
Brad Spellberg1, David N Gilbert2, Michael Baym3
1Hospital Administration, Los Angeles General Medical Center, Los Angeles, CA 90033, United States.
Health affairs scholar
|February 7, 2025
概括
帕斯泰尔法案提出60亿美元用于抗生素开发,但新的药物批准已经在增加. 建议采取激励管理和支持非营利性发现等替代策略来打击抗菌素耐药性 (AMR).
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 卫生政策 卫生政策
背景情况:
- 抗菌素耐药性 (AMR) 是一个日益增长的全球健康威胁.
- 拟议的开创性抗菌素订阅以结束抗药性反弹 (PASTEUR) 法案旨在通过为抗生素开发提供大量财政补贴来解决AMR问题.
- 最近的趋势显示,在过去15年中,抗生素临床开发和美国食品和药物管理局 (FDA) 批准的数量有所增加.
研究的目的:
- 评估PASTEUR法案拟议的补贴的必要性和有效性.
- 提出替代性和补充性的策略来打击抗菌素耐药性和稳定抗生素市场.
- 倡导政策变化,解决AMR的驱动因素,并优化抗生素开发.
主要方法:
- 对抗生素开发趋势和FDA批准的分析.
- 拟议补贴与替代干预措施的经济和政策分析.
- 根据科学证据和市场动态制定建议.
主要成果:
- 临床开发和FDA批准的抗生素数量已经显著增加.
- 目前的经济补贴可能不是对抗抗药物耐药性的最有效或最有效的方法.
- 专注于减少选择性压力和优化市场稳定性的替代策略显示出有希望.
结论:
- 通过绩效支付和管理培训来减少选择性压力至关重要.
- 建议将研发资金集中在减少对抗生素依赖的战略上.
- 建立咨询委员会和支持非营利性发现可以稳定抗生素市场,促进可持续创新.
更多相关视频
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
6.3K
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
4.5K
相关概念视频
00:57Antibiotic Selection
52.2K
Overview
52.2K
01:23Antimicrobial Proteins
875
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
875
01:31Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
01:18Surface Membrane Barriers
1.0K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.0K
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
01:33Bacterial Transformation
55.1K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
55.1K